UBA7

 

Full name: ubiquitin like modifier activating enzyme 7 Alias Symbol: D8|UBE2|UBA1B
Type: protein-coding gene Cytoband: 3p21.31
Entrez ID: 7318 HGNC ID: HGNC:12471 Ensembl Gene: ENSG00000182179 OMIM ID: 191325
Drug and gene relationship at DGIdb

 

Expression of UBA7:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE53622 UBA7 7318 8615 -0.4861 0.0000
GSE53624 UBA7 7318 8615 -0.4398 0.0000
GSE97050 UBA7 7318 A_23_P21207 0.1896 0.5095
SRP007169 UBA7 7318 RNAseq -1.1366 0.0418
SRP008496 UBA7 7318 RNAseq -1.1729 0.0018
SRP064894 UBA7 7318 RNAseq -0.0099 0.9604
SRP133303 UBA7 7318 RNAseq -0.8215 0.0004
SRP159526 UBA7 7318 RNAseq -1.2042 0.0028
SRP193095 UBA7 7318 RNAseq -0.4309 0.0472
SRP219564 UBA7 7318 RNAseq -0.0615 0.7876
TCGA UBA7 7318 RNAseq -0.3145 0.0041

Upregulated datasets: 0; Downregulated datasets: 3.  


 

Survival by UBA7 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of UBA7:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 UBA7 7318 0 18 12
GSE20123 UBA7 7318 0 19 11
GSE43470 UBA7 7318 0 18 25
GSE46452 UBA7 7318 2 16 41
GSE47630 UBA7 7318 1 24 15
GSE54993 UBA7 7318 6 2 62
GSE54994 UBA7 7318 0 35 18
GSE60625 UBA7 7318 5 0 6
GSE74703 UBA7 7318 0 14 22
GSE74704 UBA7 7318 0 12 8
TCGA UBA7 7318 0 77 19

Total number of gains: 14; Total number of losses: 235; Total Number of normals: 239.  


 

Somatic mutations of UBA7:

 

Generating mutation plots.

 

Highly correlated genes for UBA7:

 

Showing top 20/70 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
UBA7ACSL50.702218404
UBA7HLA-DMA0.699235404
UBA7VAMP50.697123303
UBA7CD740.696289403
UBA7CD3E0.693097303
UBA7PARP150.689337303
UBA7GRAP20.688228303
UBA7GNGT20.68256303
UBA7GIMAP60.682197303
UBA7GIMAP70.681629404
UBA7GPR1710.680534303
UBA7SAMD9L0.677109404
UBA7IKZF30.671615303
UBA7GIMAP10.669484303
UBA7ACAP10.663743403
UBA7IL2RG0.659634303
UBA7CD20.65796403
UBA7PIK3R60.65527303
UBA7TRIM220.65521403
UBA7IL150.654628303

For details and further investigation, click here